Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Poor Performance Status”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Large-scale testing (Phase 3)Ended earlyNCT00526643
What this trial is testing

CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients

Who this might be right for
Non-Small Cell Lung Cancer
National Cancer Institute, Naples 57
Large-scale testing (Phase 3)Study completedNCT01459497
What this trial is testing

Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University of Texas Southwestern Medical Center 103
Testing effectiveness (Phase 2)Study completedNCT00006259
What this trial is testing

Stereotactic Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Metastatic Cancer
Case Comprehensive Cancer Center 10
Not applicableStudy completedNCT01704976
What this trial is testing

SR-WBV Training for Frail Elderly in the Skilling up Stage

Who this might be right for
Poor Performance StatusMuscle Weakness
Bern University of Applied Sciences 27
Large-scale testing (Phase 3)Study completedNCT00040885
What this trial is testing

Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)

Who this might be right for
AnorexiaCachexiaFatigue+1 more
Alliance for Clinical Trials in Oncology 67
Early research (Phase 1)UnknownNCT05826483
What this trial is testing

Almonertinib in the First-line Treatment of Patients of NSCLC With Poor Performance Status

Who this might be right for
Malignant Tumor of LungPoor Performance Status
Guangzhou Institute of Respiratory Disease 20
Not applicableStudy completedNCT05166564
What this trial is testing

The PROtein Enriched MEDiterranean Diet and EXercise Trial for Older Adults At Risk of Undernutrition

Who this might be right for
Cognitive ImpairmentPoor NutritionCognitive Decline
Queen's University, Belfast 105
Testing effectiveness (Phase 2)Study completedNCT00389584
What this trial is testing

Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCognitive/Functional EffectsLong-term Effects Secondary to Cancer Therapy in Adults+4 more
University of California, Davis 30
Not applicableStudy completedNCT02332083
What this trial is testing

Innovative Training Program for Elderly in Need of Care

Who this might be right for
Poor Performance StatusCognition - Other
Bern University of Applied Sciences 17
Testing effectiveness (Phase 2)Ended earlyNCT01474551
What this trial is testing

Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 2
Early research (Phase 1)Study completedNCT01839981
What this trial is testing

CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
Wake Forest University Health Sciences 10
Testing effectiveness (Phase 2)Study completedNCT00892710
What this trial is testing

Trial of Poor Performance Status Patients (ToPPS)

Who this might be right for
Non Small Cell Lung Cancer
SCRI Development Innovations, LLC 172
Not applicableStudy completedNCT00445731
What this trial is testing

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Cancer
University of Minnesota 115
Early research (Phase 1)Ended earlyNCT00287859
What this trial is testing

Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Masonic Cancer Center, University of Minnesota 5
Not applicableStudy completedNCT03623334
What this trial is testing

Phase I Study of Accelerated Hypofractionated Image-Guided Radiation Therapy

Who this might be right for
Non-small Cell Lung Cancer
University of Texas Southwestern Medical Center 55
Testing effectiveness (Phase 2)Study completedNCT00193323
What this trial is testing

Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients

Who this might be right for
Lung Cancer
SCRI Development Innovations, LLC 346
Large-scale testing (Phase 3)Study completedNCT00259064
What this trial is testing

Iressa v BSC (Best Supportive Care) in First Line NSCLC

Who this might be right for
NSCLC
AstraZeneca 216
Testing effectiveness (Phase 2)Study completedNCT01415011
What this trial is testing

Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
University College, London 39
Testing effectiveness (Phase 2)Study completedNCT00508144
What this trial is testing

Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 64
Load More Results